Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can mindfulness calm the mind and improve sleep for dialysis patients?

NCT ID NCT07816354

Symptom relief Sponsor: Jordan University of Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are testing whether a guided mindfulness program can help adults with end-stage kidney disease who receive hemodialysis. The program involves listening to audio recordings for 30 minutes, three times a week for five weeks, during regular dialysis sessions. The study measures changes in sleep quality, depression, anxiety, stress, and emotion regulation. Thirty-eight patients at a hospital in Saudi Arabia take part, with half receiving the mindfulness program immediately and half receiving it after the study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a guided mindfulness-based intervention delivered through audio recordings
What this could lead to
If it works, mindfulness could become a low-cost, drug-free way to help dialysis patients sleep better and feel less depressed or anxious.
What could go wrong
The study is small, with only 38 patients, and mindfulness may not produce meaningful changes in sleep or mood. Participants must be willing to practice regularly during dialysis sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

38 people

The number who actually took part.

Started

Jan 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being aged 18 or above * having a history of maintenance dialysis for three months * having the capacity to self-report Exclusion Criteria: * Having acute psychiatric illness or substantial cognitive dysfunction * Involving in frequent meditation or yoga practice.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End stage chronic renal failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

End stage chronic renal failure Hemodialysis

Contacts and locations

Locations

  • Dr. Sulima Fakeeh Hospital

    Jeddah, Mecca Region, 23717, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.